| Anaplan Introduces the Agentic Enterprise, a Trusted AI-Driven Decision Infrastructure That Drives Efficient Resource Allocation and Increased Decision Quality and Velocity at Scale |
Globe Newswire |
06/30 |
08:00 |
| Biodexa Announces Pricing of $3.5 Million Registered Direct Offering & Concurrent Private Placement of Pre-Funded Warrants and Warrants |
Globe Newswire |
06/30 |
08:00 |
| Crédit Agricole CIB and Pasqal advance their strategic partnership to deploy quantum computing applied to finance |
Globe Newswire |
06/30 |
08:00 |
| Allarity Therapeutics Announces the Grant of Essential U.S. Patent for Its Stenoparib DRP® Companion Diagnostic |
Globe Newswire |
06/30 |
08:00 |
| Monopar Therapeutics Receives FDA Rare Pediatric Disease Designation for ALXN1840 for the Treatment of Wilson Disease |
Globe Newswire |
06/30 |
08:00 |
| Leonardo DRS Schedules Second Quarter 2026 Earnings Conference Call for July 30, 2026 |
Globe Newswire |
06/30 |
08:00 |
| Hyperscaler-Led Open Line System Revenue in the United States to Reach US$5 Billion by 2035 as Distributed AI Data Centers Reshape Optical Connectivity |
Globe Newswire |
06/30 |
08:00 |
| Aduro Clean Technologies and AstroTurf Sign MOU for Synthetic Turf Recycling |
Globe Newswire |
06/30 |
08:00 |
| Design Therapeutics Announces Initiation of Patient Dosing in Phase 1 Multiple Ascending Dose Trial of DT-818 for Myotonic Dystrophy Type-1 |
Globe Newswire |
06/30 |
08:00 |
| Sharplink Acquires 10,000 ETH, Bringing Total ETH Holdings to 886,725; Repurchases Over 2.1 Million Shares of Common Stock |
Globe Newswire |
06/30 |
08:00 |
| Quince Therapeutics Appoints Recognized Leaders in Pulmonary Medicine to Scientific Advisory Board |
Globe Newswire |
06/30 |
08:00 |
| MediciNova CEO Provides Shareholder Update |
Globe Newswire |
06/30 |
08:00 |
| Innventure Announces Appointment of Dr. Bill Grieco as CEO following Retirement of Current CEO Bill Haskell |
Globe Newswire |
06/30 |
08:00 |
| KashKick Survey Reveals Mobile Gaming as a Daily Habit and Income Source for Americans |
Globe Newswire |
06/30 |
08:00 |
| U.S. Renal Care and Akebia Announce Interim Analysis of VOICE Trial Demonstrated Overwhelming Statistical Evidence of Improved Safety Outcomes for Patients Treated with Vafseo versus an ESA |
Globe Newswire |
06/30 |
08:00 |
| ALX Oncology Appoints Scott Garland as Chairman of the Board and Michael Listgarten as General Counsel |
Globe Newswire |
06/30 |
08:00 |
| Lands’ End Announces CEO Transition, Positioning Company for Next Phase of Growth |
Globe Newswire |
06/30 |
08:00 |
| Cogent Biosciences Announces Submission of New Drug Application (NDA) for Bezuclastinib in Advanced Systemic Mastocytosis (AdvSM) |
Globe Newswire |
06/30 |
08:00 |
| SCYNEXIS Initiates Phase 1 Study of SCY-770, a Novel AMPK Activator for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD) |
Globe Newswire |
06/30 |
08:00 |
| LB Pharmaceuticals Appoints Christopher Zergebel as Senior Vice President, Clinical Operations |
Globe Newswire |
06/30 |
08:00 |
| Kneat Files Management Information Circular in Connection with the Previously Announced Thoma Bravo Transaction |
Globe Newswire |
06/30 |
07:57 |
| Eos Energy Announces Updated Terms for Rights Offering |
Globe Newswire |
06/30 |
07:50 |
| Eos Announces Pricing of Registered Direct Offering of Common Stock and Warrants to Fund Investment in Frontier Power USA |
Globe Newswire |
06/30 |
07:45 |
| FocalTherics™ Announces Successful Launch of First Commercial Endometriosis Focal One® Program in Europe with Treatment of Initial Patients |
Globe Newswire |
06/30 |
07:30 |
| InflaRx Assessing Feasibility of Broadened Strategy for ANCA‑Associated Vasculitis in Europe Following EMA Recommendation on Tavneos |
Globe Newswire |
06/30 |
07:30 |
